The Use of Glucocorticoid in the Management of Adverse Effects Related to Immunocheckpoint Inhibitor...
The Use of Glucocorticoid in the Management of Adverse Effects Related to Immunocheckpoint Inhibitors
About this item
Full title
Author / Creator
Wang, Hanping , Zhou, Jiaxin , Guo, Xiaoxiao , Li, Yue , Duan, Lian , Si, Xiaoyan and Zhang, Li
Publisher
China: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Journal title
Language
Chinese
Formats
Publication information
Publisher
China: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Subjects
More information
Scope and Contents
Contents
Immunocheckpoint inhibitors (ICIs) activated the patients' tumor immunity to kill the tumor cell, and brought new hope to patients with tumor. However, a series of immunocheckpoint inhibitors related adverse effects (irAEs) may also occur based on immune injury. Glucocorticoids are the basis for the treatment of such irAEs. However, the usage, dosa...
Alternative Titles
Full title
The Use of Glucocorticoid in the Management of Adverse Effects Related to Immunocheckpoint Inhibitors
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7e24847103454cfabe460132d443824d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7e24847103454cfabe460132d443824d
Other Identifiers
ISSN
1009-3419
E-ISSN
1999-6187
DOI
10.3779/j.issn.1009-3419.2019.10.02
